inclusion criteria: * the covid-19 patient who diagnosed by pcr within 3 days prior to randomized and who is hospitalized with covid-19 related symptoms * the subject who has symptoms of covid-19 within 7 days * the subject with pneumonia confirmed by imaging diagnosis related to covid-19 or a 70-year-old or older or 60-year-old or older with underlying disease (diabetes or hypertension or obesity or smoker) * willing and able to provide written informed consent prior to performing study procedures

inclusion criteria: * the covid-19 patient who diagnosed by pcr within 3 days prior to randomized and who is hospitalized with covid-19 related symptoms * the subject who has symptoms of covid-19 within 7 days * the subject with pneumonia confirmed by imaging diagnosis related to covid-19 or a 70-year-old or older or 60-year-old or older with underlying disease (diabetes or hypertension or obesity or smoker) * willing and able to provide written informed consent prior to performing study procedures

inclusion criteria: - the covid-19 patient who diagnosed by pcr within 3 days prior to randomized and who is hospitalized with covid-19 related symptoms - the subject who has symptoms of covid-19 within 7 days - the subject with pneumonia confirmed by imaging diagnosis related to covid-19 or a 70-year-old or older or 60-year-old or older with underlying disease (diabetes or hypertension or obesity or smoker) - willing and able to provide written informed consent prior to performing study procedures

inclusion criteria: - the covid-19 patient who diagnosed by pcr within 3 days prior to randomized and who is hospitalized with covid-19 related symptoms - the subject who has symptoms of covid-19 within 7 days - the subject with pneumonia confirmed by imaging diagnosis related to covid-19 or a 70-year-old or older or 60-year-old or older with underlying disease (diabetes or hypertension or obesity or smoker) - willing and able to provide written informed consent prior to performing study procedures